Skip to main content
BLFS
NASDAQ Life Sciences

BioLife Q2 Revenue Jumps 21% to $28.5M, Operating Income Swings to Profit

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$33.93
Mkt Cap
$1.66B
52W Low
$17.86
52W High
$34.34
52W Position info
90% above low
Off High info
1.2% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BLFS sits 90% above its 52-week low of $17.86.

Summary

BioLife Solutions delivered a strong Q2 with revenue up 21% YoY to $28.5 million, driven by its dominant biopreservation media franchise. GAAP operating income swung to a $1.7 million profit from a $16.1 million loss a year ago, while adjusted EBITDA hit $7.4 million — a 26% margin. The company's media is now embedded in 18 commercial cell and gene therapies and holds over 70% market share in U.S. clinical trials. This performance reinforces the rationale behind Repligen's $1.5 billion acquisition announced in July, which is expected to close in Q4 2026. The 10-Q discloses merger consideration of $11.25 cash plus 0.1442 Repligen shares per BioLife share, and Q2 net income of $45.1 million including a $42.4 million tax benefit. The results show accelerating profitability and market penetration ahead of the merger.

Updated with an SEC 10-Q filing · What changed

Updates

  1. · SEC 10-Q — The 10-Q discloses merger consideration of $11.25 cash plus 0.1442 Repligen shares per BioLife share, and Q2 net income of $45.1M including a $42.4M tax benefit.

At the time of this announcement, BLFS was trading at $33.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $17.86 to $34.34. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

BLFS - Latest Insights

BLFS
Oct 06, 2026, 9:11 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.00
Real-time Price: $39.00 info
Change: $0 (0%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info